| Ellie Mental Health Boca Raton | |
|
2201 Nw Corporate Blvd Ste 101 Boca Raton FL 33431-7337 | |
| (561) 617-8751 | |
| (561) 423-0711 |
| Full Name | Ellie Mental Health Boca Raton |
|---|---|
| Speciality | Counselor |
| Location | 2201 Nw Corporate Blvd Ste 101, Boca Raton, Florida |
| Authorized Official Name and Position | David Rojas (OWNER) |
| Authorized Official Contact | 3057464573 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ellie Mental Health Boca Raton 2201 Nw Corporate Blvd Ste 101 Boca Raton FL 33431-7337 Ph: (561) 617-8751 | Ellie Mental Health Boca Raton 2201 Nw Corporate Blvd Ste 101 Boca Raton FL 33431-7337 Ph: (561) 617-8751 |
| NPI Number | 1053020271 |
|---|---|
| Provider Enumeration Date | 11/16/2022 |
| Last Update Date | 03/13/2023 |
| Certification Date | 03/13/2023 |
| Medicare PECOS PAC ID | 6406219815 |
|---|---|
| Medicare Enrollment ID | O20230901001743 |
News Archive
On World Cancer Day 2015, ESMO acknowledges patient's right to access treatment and highlights collaborative efforts towards improving access for all.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
The start of the school year is here again, but for some young people, it can mean serious worry about what may lay ahead.
The World Health Organization (WHO) welcomes the action by more and more Member States to adopt the Global Solar Ultraviolet (UV) Index. In recent days, Canada and the United States of America have begun using the Index (UVI), joining several other WHO Member States, to ensure that the UVI is used on a regular basis to educate people about the dangers of overexposure to UV radiation.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053020271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Andrea Marie Maisano Del Giacco |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851846141 PECOS PAC ID: 5890059075 Enrollment ID: I20180516002202 |
News Archive
On World Cancer Day 2015, ESMO acknowledges patient's right to access treatment and highlights collaborative efforts towards improving access for all.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
The start of the school year is here again, but for some young people, it can mean serious worry about what may lay ahead.
The World Health Organization (WHO) welcomes the action by more and more Member States to adopt the Global Solar Ultraviolet (UV) Index. In recent days, Canada and the United States of America have begun using the Index (UVI), joining several other WHO Member States, to ensure that the UVI is used on a regular basis to educate people about the dangers of overexposure to UV radiation.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
› Verified 4 days ago
| Provider Name | Cassondra Lee Kelchner |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1063156065 PECOS PAC ID: 8729437470 Enrollment ID: I20231207000786 |
News Archive
On World Cancer Day 2015, ESMO acknowledges patient's right to access treatment and highlights collaborative efforts towards improving access for all.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
The start of the school year is here again, but for some young people, it can mean serious worry about what may lay ahead.
The World Health Organization (WHO) welcomes the action by more and more Member States to adopt the Global Solar Ultraviolet (UV) Index. In recent days, Canada and the United States of America have begun using the Index (UVI), joining several other WHO Member States, to ensure that the UVI is used on a regular basis to educate people about the dangers of overexposure to UV radiation.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
› Verified 4 days ago
| Provider Name | Tina Lambert |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1124534870 PECOS PAC ID: 8527417047 Enrollment ID: I20231209000344 |
News Archive
On World Cancer Day 2015, ESMO acknowledges patient's right to access treatment and highlights collaborative efforts towards improving access for all.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
The start of the school year is here again, but for some young people, it can mean serious worry about what may lay ahead.
The World Health Organization (WHO) welcomes the action by more and more Member States to adopt the Global Solar Ultraviolet (UV) Index. In recent days, Canada and the United States of America have begun using the Index (UVI), joining several other WHO Member States, to ensure that the UVI is used on a regular basis to educate people about the dangers of overexposure to UV radiation.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
› Verified 4 days ago
| Provider Name | Jessica Lyn Mclymont |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1114326634 PECOS PAC ID: 0941663355 Enrollment ID: I20240108006244 |
News Archive
On World Cancer Day 2015, ESMO acknowledges patient's right to access treatment and highlights collaborative efforts towards improving access for all.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
The start of the school year is here again, but for some young people, it can mean serious worry about what may lay ahead.
The World Health Organization (WHO) welcomes the action by more and more Member States to adopt the Global Solar Ultraviolet (UV) Index. In recent days, Canada and the United States of America have begun using the Index (UVI), joining several other WHO Member States, to ensure that the UVI is used on a regular basis to educate people about the dangers of overexposure to UV radiation.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
› Verified 4 days ago
News Archive
On World Cancer Day 2015, ESMO acknowledges patient's right to access treatment and highlights collaborative efforts towards improving access for all.
For the third year in a row, the American Society of Clinical Oncology (ASCO) has included Erbitux® (cetuximab) research in its annual report, Clinical Cancer Advances, which features the most significant studies of 2010. The report cites as a notable advance this year the finding that BRAF mutation status is a prognostic, not predictive, marker for Erbitux efficacy in metastatic colorectal cancer (mCRC).
The start of the school year is here again, but for some young people, it can mean serious worry about what may lay ahead.
The World Health Organization (WHO) welcomes the action by more and more Member States to adopt the Global Solar Ultraviolet (UV) Index. In recent days, Canada and the United States of America have begun using the Index (UVI), joining several other WHO Member States, to ensure that the UVI is used on a regular basis to educate people about the dangers of overexposure to UV radiation.
Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced the issuance of Patent No. 7,749,730 B2 by the U.S. Patent and Trademark Office entitled "High Throughput Screening Assay for the TRPm5 Ion Channel."
› Verified 4 days ago
Meryl B. Rome, Md, Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7100 W Camino Real, Ste. 207, Boca Raton, FL 33433 Phone: 561-391-2770 Fax: 561-391-2930 | |
Kegley Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3200 N Federal Hwy Ste 206-7, Boca Raton, FL 33431 Phone: 404-496-8849 Fax: 404-591-7909 | |
Lifetime Health Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 433 Plaza Real Ste 275, Boca Raton, FL 33432 Phone: 786-226-5377 | |
Creative Minds Aba Services Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1700 N Dixie Hwy Ste 122, Boca Raton, FL 33432 Phone: 305-305-3181 | |
Ronald L Seifer Ph D Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7300 W Camino Real, Suite 230, Boca Raton, FL 33433 Phone: 561-699-7455 Fax: 954-340-3407 | |
James Cocores Md Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5301 N Federal Hwy, Suite 270, Boca Raton, FL 33487 Phone: 561-989-9393 Fax: 561-989-9369 | |
L. Dennison Reed, Psy.d., P.a. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4710 Nw Boca Raton Blvd, Suite 104, Boca Raton, FL 33431 Phone: 954-427-8883 Fax: 954-427-3813 |